DSIP 99% Purity Weight Loss Peptide Cagrilintide Fast Shipping
18 Inquiries
62568-57-4
Pharmaceutical Grade
99.8%
Shenzhen
HuiTu
10mg,12mg,15mg/vial;1g/bag
2026-10-09
Peptides,Retatrutide,GHK-CU
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceA nonapeptide that is found in neurons, peripheral organs, and plasma. This neuropeptide induces mainly delta sleep in mammals. In addition to sleep, the peptide has been observed to affect electrophysiological activity, neurotransmitter levels in the brain, circadian and locomotor patterns, hormonal levels, psychological performance, and the activity of neuropharmacological drugs including their withdrawal.Basic Info
-
Product Name:
Dsip
CAS No.:62568-57-4
Molecular Formula:C35H48N10O15
InChIKeys:ZRZROXNBKJAOKB-GFVHOAGBSA-N
Molecular Weight:848.8
Exact Mass:848.33006086
UNII:YN28Z5YZ73
Categories:
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptides,Retatrutide,GHK-CU
-
Location:
Room 503, 5th Floor, Office Unit 501, New Triumphal Arch Health Products Mall, Changzheng Road, Chengguan Town, Taihe County, Fuyang City, Anhui Province
-
Payment Terms:
TT against copy of documents,D/P,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
3 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
-
Inquiry History18 Inquiries
Country Product Purchase Quantity Date Posted 
United Kingdom
Dsip
10 MG Jun 17, 2026 
United States
Dsip
10 G Jan 12, 2026
United States
dsip
100 G May 17, 2026
United States
DSIP
10 MT Apr 27, 2026
United States
DSIP
10 Apr 13, 2026
United States
DSIP
1 MT Apr 10, 2026
United States
Dsip
100 MT Feb 3, 2026
United States
Dsip
1 MT Dec 17, 2025 
Italy
Adipotide
100 MG Jun 2, 2024
United States
DSIP
100 MG Nov 28, 2025 
Germany
Dsip
1 MT Apr 26, 2026
United States
DSIP
10 MT Mar 12, 2026
United States
DSIP
10 MG Jan 12, 2026
United States
DSIP
1 G Nov 10, 2025
United States
dsip
1 Oct 20, 2025
United States
DSIP lyphilized powder
100 MG Jun 24, 2025
United States
Adipotide 5mg 10vial kit
1 MT Feb 25, 2024
United States
Epitalon, NAD+, DSIP, 5-Amino-1MQ, PEG-MGF
1 May 9, 2026 Post an enquiry for this product
More from this Seller
-
-
![TSM | 99% High Purity | CAS 112603-35-7 Peptide | US Warehouse | 10mg]( "TSM | 99% High Purity | CAS 112603-35-7 Peptide | US Warehouse | 10mg")
-
TSM | 99% High Purity | CAS 112603-35-7 Peptide | US Warehouse | 10mg
Pharmaceutical Grade / 99%
-
-
-
![Adamax 20mg 30mg for Weight loss peptide with test report]( "Adamax 20mg 30mg for Weight loss peptide with test report")
-
Adamax 20mg 30mg for Weight loss peptide with test report
Pharmaceutical Grade / 99.8%
$5-6/G FOB
-
-
-
![Tirzepatide RT BAC l 10mg l 99% High purity l Weight Loss Fitness l CAS 2023788-19-2 l GLP-1 Peptides l US Warehouse]( "Tirzepatide RT BAC l 10mg l 99% High purity l Weight Loss Fitness l CAS 2023788-19-2 l GLP-1 Peptides l US Warehouse")
-
Tirzepatide RT BAC l 10mg l 99% High purity l Weight Loss Fitness l CAS 2023788-19-2 l GLP-1 Peptides l US Warehouse
Pharmaceutical Grade / 99%
$5E+1/UNIT FOB
-
-
-
![FOX04-DRI Peptide 99% High Purity for Laboratory Research Tirz/Sema/Reta Peptide]( "FOX04-DRI Peptide 99% High Purity for Laboratory Research Tirz/Sema/Reta Peptide")
-
FOX04-DRI Peptide 99% High Purity for Laboratory Research Tirz/Sema/Reta Peptide
Pharmaceutical Grade / 99.8%
$5-6/G FOB
-
